IVIG Treatment Compared to Placebo in Patients With Myasthenia Gravis: A Randomized Clinical Trial

NCT00306033 Phase 3 COMPLETED

This study is a double-blind, placebo-controlled, randomized clinical trial to determine whether IVIG is effective in improving motor scores in patients with myasthenia gravis and worsening weakness.

Details

Lead sponsor	University Health Network, Toronto
Phase	Phase 3
Status	COMPLETED
Enrolment	50
Start date	2004-03
Completion	2005-05

Conditions

• Myasthenia Gravis

Interventions

• Intravenous ImmuneGlobulin

Primary outcomes

• change in the Myasthenia Gravis Foundation of America (MGFA) Quantitative MG Score for Disease Severity

Countries

Canada